JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, "Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers." Host Dr. Rafeh Naqash and Dr. Miao discuss the clinicogenomic characteristics and treatment outcomes of patients with ALK+ squamous and adenosquamous lung cancers and how these outcomes compare to those of patients with ALK+ adenocarcinoma treated with first-line alectinib.

LINK TO FULL TRANSCRIPT

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör American Society of Clinical Oncology (ASCO). Innehållet i podden är skapat av American Society of Clinical Oncology (ASCO) och inte av, eller tillsammans med, Poddtoppen.